Patent · US Active

Antisense antibacterial compounds and methods

US9790495B2 · kind B2 · utility

4Cited by
19References
38Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 15, 2015
Grant dateOct 17, 2017
Priority date
Expiry dateMay 15, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are antisense morpholino oligomers targeted against bacterial virulence factors such as genes that contribute to antibiotic resistance or biofilm formation, or genes associated with fatty acid biosynthesis, and related compositions and methods of using the oligomers and compositions, for instance, in the treatment of an infected mammalian subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.